OTC: SHRMF
After Hours
--Quotes are delayed by 20 min
Jan 21, 2021, 4:11 p.m.
$
0.65
Change
+0.02 +2.49%
Volume
Volume 2,000
Quotes are delayed by 20 min
Previous close
$ 0.65
$ 0.64
Change
-0.01 -1.69%
Day low
Day high
$0.60
$0.70
52 week low
52 week high
$0.22
$1.74
Data not available.
Dr. Roger McIntyre Chairman & Chief Executive Officer |
Mr. Matthew Fish President, Secretary & Director |
Mr. Stephen R. Brooks Chief Financial Officer |
Dr. Bill Wilkerson Vice Chairman |
Mr. Peter Rizakos General Counsel |
Mr. Jerry Habuda Independent Director |
Climate activist Greta Thunberg chides Sen. Ted Cruz’s preference for a ‘Pittsburgh Accord’
Baker Hughes stock price target raised to $28 from $20 at Stephens
Dow futures skid 250 points as focus on COVID lockdown measures heats up
Facebook stock price target raised to $345 from $300 at Oppenheimer
DermTech started at outperform with $53 stock price target at Oppenheimer
Option Care Health started at buy with $22 stock price target at Deutsche Bank
INmune Bio stock price target raised to $32 from $16 at Maxim Group
Heat Biologics stock price target cut to $22 from $35 at Maxim Group
Bionano Genomics stock price target raised to $14 from $2 at Maxim Group
Quidel upgraded to outperform from market perform at Raymond James
Medical Properties Trust downgraded to hold from buy at Truist
Fear of new virus variant pushes U.S. toward more genomic sequencing
Columbia Property Trust downgraded to hold from buy at Truist
Grocery sales soared in 2020 due to COVID-19, but analysts forecast a 2021 crash back to Earth
Virtual Stock Exchange